Hatton Mark W C, Southward Suzanne M R, Ross Bonnie L, Clarke Bryan J, Singh Gurmit, Richardson Mary
Department of Pathology & Molecular Medicine, McMaster University Health Sciences Centre, Hamilton, Ontario, Canada.
J Lab Clin Med. 2006 Jan;147(1):27-35. doi: 10.1016/j.lab.2005.08.014.
The VX2 tumor is derived from a papilloma virus-induced rabbit epithelial cell line. If VX2 tumor cells (trapped in a plasma clot) are introduced intravenously into NZW rabbits, the cells lodge in the lung capillary bed and produce tumors. Independently of the tumor burden (ie, the total tumor weight per rabbit), approximately 15% of rabbits with VX2 lung tumors accumulate an effusion in the interpleural space and this pleural effusion contains products of hemostasis. We hypothesized that these products were of intra-tumoral origin and that they changed in concentration as tumor burden increased. Interrelationships among lung-, tumor-weights, and pleural effusion volumes, and the concentrations of fibrinolytic factors, their catabolic products, and other proteins of pleural effusions were measured in rabbits with a wide range of tumor burdens. Positive correlations between tumor burden and total lung weight and between pleural effusion volume and net lung weight suggested that interstitial fluid from the stroma of tumors passed directly into the extravascular space of the lung(s) and into the interpleural space(s). Analyses of pleural effusions indicated that plasminogen-, alpha(2)-antiplasmin-, and plasminogen activator inhibitor-1-related proteins, urokinase-like- and tissue-plasminogen activator activities, and vascular endothelial growth factor increased in concentration up to a tumor burden of approximately 20-25 g. Plasmin activity and intact fibrinogen were absent. The concentration of fibrin(ogen) degradation products did not change significantly up to a tumor burden of approximately 25 g but increased substantially as tumor burdens exceeded 25 g. In conclusion, interstitial fluid from tumors enters the extravascular space of the host and may accumulate with fluid from non-tumor sources as a pleural effusion. The concentrations of fibrinolytic factors and their products in pleural effusions reflect the tumor burden of the rabbit. Conceivably, the components of a malignant effusion contain much information about the extent of tumor growth.
VX2肿瘤源自乳头瘤病毒诱导的兔上皮细胞系。如果将VX2肿瘤细胞(包埋于血浆凝块中)经静脉注入新西兰白兔体内,这些细胞会滞留在肺毛细血管床并形成肿瘤。与肿瘤负荷(即每只兔子的肿瘤总重量)无关,约15%患有VX2肺肿瘤的兔子会在胸膜腔隙中积聚积液,且这种胸腔积液含有止血产物。我们推测这些产物源自肿瘤内部,且其浓度会随着肿瘤负荷的增加而变化。我们测量了肿瘤负荷范围广泛的兔子的肺重量、肿瘤重量和胸腔积液体积之间的相互关系,以及胸腔积液中纤溶因子及其分解产物和其他蛋白质的浓度。肿瘤负荷与肺总重量之间以及胸腔积液体积与肺净重量之间呈正相关,这表明肿瘤间质液直接进入肺的血管外间隙并进入胸膜腔隙。对胸腔积液的分析表明,纤溶酶原、α(2)-抗纤溶酶和纤溶酶原激活物抑制剂-1相关蛋白、尿激酶样和组织纤溶酶原激活物活性以及血管内皮生长因子的浓度在肿瘤负荷约为20 - 25 g之前会升高。不存在纤溶酶活性和完整的纤维蛋白原。纤维蛋白(原)降解产物的浓度在肿瘤负荷约为25 g之前没有显著变化,但当肿瘤负荷超过25 g时会大幅增加。总之,肿瘤间质液进入宿主的血管外间隙,并可能与非肿瘤来源的液体一起积聚形成胸腔积液。胸腔积液中纤溶因子及其产物的浓度反映了兔子的肿瘤负荷。可以想象,恶性积液的成分包含了许多关于肿瘤生长程度的信息。